Diligence memo · auto-generated · as of July 2, 2026
Scythian Biosciences Inc.
Scythian Biosciences Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Scythian Biosciences Inc. operates in Biotechnology, based in CALGARY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Scythian Biosciences Inc. has raised $462K in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $170K on 2014-12-11.
Most recent recorded round closed around 2015-07-20.
Valuation (modeled)modeled
Provath models Scythian Biosciences Inc. at approximately $9.4M (range $91K–$107M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.59× the median modeled value of Pre-Seed Biotechnology companies in 2013–2015 (131 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 4 months.
Last raise 11.0 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.4× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 10% of Biotechnology peers (4293 compared).
Modeled value ranks above 18% of those peers.
Closest niche peers: Imanis Life Sciences, LLC, Truminim, LLC, Direct Spinal Therapeutics, Inc., Universal Biosensors Inc, One World Lab, Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.